|
Name |
1,8-Dihydroxy-3-methoxy-6-methylxanthone
|
Molecular Formula | C15H12O5 | |
IUPAC Name* |
1,8-dihydroxy-3-methoxy-6-methylxanthen-9-one
|
|
SMILES |
CC1=CC(=C2C(=C1)OC3=CC(=CC(=C3C2=O)O)OC)O
|
|
InChI |
InChI=1S/C15H12O5/c1-7-3-9(16)13-11(4-7)20-12-6-8(19-2)5-10(17)14(12)15(13)18/h3-6,16-17H,1-2H3
|
|
InChIKey |
QQWCJIAJCYGAIK-UHFFFAOYSA-N
|
|
Synonyms |
1,8-dihydroxy-3-methoxy-6-methylxanthone; 1,8-dihydroxy-3-methoxy-6-methyl-9H-xanthen-9-one; CHEBI:68287; DTXSID101234603; 1,8-dihydroxy-3-methoxy-6-methylxanthen-9-one; 1,8-Dihydroxy-3-methoxy-6-methyl-9H-xanthene-9-one; Q27136781; 1043624-67-4
|
|
CAS | 1043624-67-4 | |
PubChem CID | 25034673 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 272.25 | ALogp: | 3.1 |
HBD: | 2 | HBA: | 5 |
Rotatable Bonds: | 1 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 76.0 | Aromatic Rings: | 3 |
Heavy Atoms: | 20 | QED Weighted: | 0.663 |
Caco-2 Permeability: | -4.91 | MDCK Permeability: | 0.00000891 |
Pgp-inhibitor: | 0.004 | Pgp-substrate: | 0.945 |
Human Intestinal Absorption (HIA): | 0.016 | 20% Bioavailability (F20%): | 0.006 |
30% Bioavailability (F30%): | 0.864 |
Blood-Brain-Barrier Penetration (BBB): | 0.013 | Plasma Protein Binding (PPB): | 92.06% |
Volume Distribution (VD): | 0.696 | Fu: | 8.52% |
CYP1A2-inhibitor: | 0.978 | CYP1A2-substrate: | 0.946 |
CYP2C19-inhibitor: | 0.516 | CYP2C19-substrate: | 0.088 |
CYP2C9-inhibitor: | 0.721 | CYP2C9-substrate: | 0.924 |
CYP2D6-inhibitor: | 0.745 | CYP2D6-substrate: | 0.868 |
CYP3A4-inhibitor: | 0.271 | CYP3A4-substrate: | 0.154 |
Clearance (CL): | 3.411 | Half-life (T1/2): | 0.568 |
hERG Blockers: | 0.016 | Human Hepatotoxicity (H-HT): | 0.069 |
Drug-inuced Liver Injury (DILI): | 0.923 | AMES Toxicity: | 0.553 |
Rat Oral Acute Toxicity: | 0.098 | Maximum Recommended Daily Dose: | 0.863 |
Skin Sensitization: | 0.881 | Carcinogencity: | 0.032 |
Eye Corrosion: | 0.429 | Eye Irritation: | 0.98 |
Respiratory Toxicity: | 0.393 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC001750 | 0.774 | D0K8KX | 0.386 | ||||
ENC003136 | 0.710 | D04AIT | 0.378 | ||||
ENC002462 | 0.667 | D06GCK | 0.363 | ||||
ENC005647 | 0.647 | D07MGA | 0.318 | ||||
ENC001749 | 0.620 | D0G4KG | 0.271 | ||||
ENC001653 | 0.594 | D0FA2O | 0.259 | ||||
ENC004846 | 0.594 | D0G5UB | 0.250 | ||||
ENC005808 | 0.594 | D0S5CH | 0.250 | ||||
ENC005191 | 0.594 | D0AZ8C | 0.244 | ||||
ENC006013 | 0.592 | D04UTT | 0.243 |